Literature DB >> 23263898

High rates of physician services utilization at least five years before multiple sclerosis diagnosis.

Ruth Ann Marrie1, Nancy Yu, Yichuan Wei, Lawrence Elliott, James Blanchard.   

Abstract

BACKGROUND: Multiple sclerosis (MS) management has changed over time, but changes in health care utilization by MS patients remain understudied. We estimated physician services utilization in the five-year periods before and after MS diagnosis, and over the period 1984-2008.
METHODS: Using administrative data we identified 4092 persons with MS and a matched general population (GPOP) cohort of 21,446 persons. Using general linear models we compared physician visits between the MS and GPOPs for the period 1984-2008, the year of MS diagnosis, and for the five-year periods pre- and post-diagnosis.
RESULTS: From 1984 to 2008, 98% of the MS population averaged ≥1 physician visits/year versus 87% of the GPOP. In 2008, the MS population had 12.9 physician visits/person-year while the GPOP had 8.4 (rate ratio (RR) 1.53; 95% confidence interval (CI): 1.52-1.55). Five years pre-MS diagnosis, the MS population had more physician visits than the GPOP (RR 1.15; 95% CI; 1.10-1.21). The number of visits peaked the year of MS diagnosis (19.0), decreasing thereafter, but remaining elevated versus the pre-diagnosis period.
CONCLUSION: The MS population uses more physician services than the GPOP, starting at least five years pre-MS diagnosis. A better understanding of the reasons for these higher utilization rates may ultimately improve outcomes in MS.

Entities:  

Keywords:  Multiple sclerosis; administrative data; cohort; health care utilization

Mesh:

Year:  2012        PMID: 23263898     DOI: 10.1177/1352458512471877

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  16 in total

Review 1.  Lifestyle and Environmental Factors in Multiple Sclerosis.

Authors:  Lars Alfredsson; Tomas Olsson
Journal:  Cold Spring Harb Perspect Med       Date:  2019-04-01       Impact factor: 6.915

2.  Comorbidity increases the risk of hospitalizations in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-12-24       Impact factor: 9.910

Review 3.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis.

Authors:  Tomas Olsson; Lisa F Barcellos; Lars Alfredsson
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

4.  Autonomic nervous system: a key player in prodromal multiple sclerosis?

Authors:  Mario Habek; Magdalena Krbot Skorić
Journal:  Clin Auton Res       Date:  2020-03-11       Impact factor: 4.435

5.  Low testosterone is associated with disability in men with multiple sclerosis.

Authors:  R Bove; A Musallam; B C Healy; K Raghavan; B I Glanz; R Bakshi; H Weiner; P L De Jager; K K Miller; T Chitnis
Journal:  Mult Scler       Date:  2014-04-07       Impact factor: 6.312

6.  Dramatically changing rates and reasons for hospitalization in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; James Blanchard; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-08-01       Impact factor: 9.910

7.  Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis.

Authors:  Chantel D Mayo; Negar Farzam-Kia; Setareh Ghahari
Journal:  Int J MS Care       Date:  2021-02-23

8.  Differing trends in the incidence of vascular comorbidity in MS and the general population.

Authors:  Ruth Ann Marrie; John Fisk; Helen Tremlett; Christina Wolfson; Sharon Warren; James Blanchard; Scott B Patten
Journal:  Neurol Clin Pract       Date:  2016-04

9.  Sex differences in comorbidity at diagnosis of multiple sclerosis: A population-based study.

Authors:  Ruth Ann Marrie; Scott B Patten; Helen Tremlett; Christina Wolfson; Sharon Warren; Lawrence W Svenson; Nathalie Jette; John Fisk
Journal:  Neurology       Date:  2016-03-09       Impact factor: 9.910

10.  Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group.

Authors:  Chantelle Murley; Petter Tinghög; Kristina Alexanderson; Jan Hillert; Emilie Friberg; Korinna Karampampa
Journal:  Pharmacoeconomics       Date:  2021-05-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.